Development of a hybrid tablet-integrated superporous hydrogel for gastro-retentive delivery of famotidine
PLOS One · 08.05.2026 · 21 (5) · e0347426
DOI: 10.1371/journal.pone.0347426 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 08.05.2026. Verfasst von Nilima Thombre und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, MET's Institute of Pharmacy, Savitribai Phule Pune University, Bhujbal Knowledge City, Nashik, Maharashtra, India. Hauptthemen laut MEDLINE: Famotidine, Drug Delivery Systems, Hydrogel, Polyethylene Glycol Dimethacrylate, Hydrogels. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deanship of Research and Graduate Studies at King Khalid University, Abha.
Abstract (Originalsprache)
A gastro-retentive drug delivery system based on a tablet-integrated superporous hydrogel (SPH) was developed using Famotidine as a model drug for ulcer treatment. The objective of this study was to enhance gastric retention and sustained drug release, thereby improving the bioavailability of Famotidine, a BCS Class III drug with limited permeability and incomplete absorption. The SPH system was designed to retain the formulation in the upper gastrointestinal tract, the primary site of drug absorption, and was prepared using a gas-blowing (foaming) technique. A 3² full factorial design was employed to optimize the formulation by varying the concentrations of Crosspovidone and Cassia tora as independent variables. The developed SPH formulations were evaluated for porosity, swelling index, void fraction, water retention capacity, morphology, drug–excipient compatibility, and in vitro and in vivo drug release behaviour. The optimized formulation (F1) exhibited a high cumulative drug release of 98.2191 ± 0.06%, a swelling ratio of 297.2 ± 0.11%, void fraction of 0.4366 ± 0.015, porosity of 0.171 ± 0.07, and water retention time of 0.9552 ± 0.07 min. FTIR analysis confirmed the compatibility between Famotidine and excipients, while DSC studies indicated that the drug remained in its stable form without alteration during formulation. In vivo radiographic studies demonstrated that the optimized SPH formulation remained buoyant and retained in the stomach for up to 12 h, providing prolonged gastric residence and sustained drug release. Overall, the tablet-integrated SPH system represents an effective gastro-retentive approach for enhancing the therapeutic performance of Famotidine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics, MET's Institute of Pharmacy, Savitribai Phule Pune University, Bhujbal Knowledge City, Nashik, Maharashtra, India.
- Department of Pharmaceutical Chemistry, MET's Institute of Pharmacy, Savitribai Phule Pune University, Bhujbal Knowledge City, Nashik, Maharashtra, India.
- Department of Pharmacology, MET's Institute of Pharmacy, Savitribai Phule Pune University, Bhujbal Knowledge City, Nashik, Maharashtra, India.
- Department of Pharmaceutics, College of Pharmacy, King Khalid University, Abha, Saudi Arabia.
- Department of Pharmaceutical Quality Assurance, MET's Institute of Pharmacy, Savitribai Phule Pune University, Bhujbal Knowledge City, Nashik, Maharashtra, India.
- MET's Institute of Pharmacy, Savitribai Phule Pune University, Bhujbal Knowledge City, Nashik, Maharashtra, India.
ORCID-Profile: Fahadul Islam
Förderung
- Deanship of Research and Graduate Studies at King Khalid University, Abha
Zitieren
APA
Thombre, N., Chandramore, K., Tajanpure, A., Al Fatease, A., Hani, U., Alamri, A. H., Ghazwani, M., Jadhav, R., Ramaiya, M., Anumone, D., Agrawal, V., Khan, S. L., & Islam, F. (2026). Development of a hybrid tablet-integrated superporous hydrogel for gastro-retentive delivery of famotidine. PLOS One, 21(5), e0347426. https://doi.org/10.1371/journal.pone.0347426
Vancouver
Thombre N, Chandramore K, Tajanpure A, Al Fatease A, Hani U, Alamri AH, et al. Development of a hybrid tablet-integrated superporous hydrogel for gastro-retentive delivery of famotidine. PLOS One. 2026;21(5):e0347426. doi:10.1371/journal.pone.0347426
BibTeX
@article{Thombre2026,
author = {Thombre, Nilima and Chandramore, Kavita and Tajanpure, Anjali and Al Fatease, Adel and Hani, Umme and Alamri, Ali H and Ghazwani, Mohammed and Jadhav, Roshan and Ramaiya, Meeta and Anumone, Diya and Agrawal, Vedant and Khan, Sharuk L and Islam, Fahadul},
title = {Development of a hybrid tablet-integrated superporous hydrogel for gastro-retentive delivery of famotidine},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {5},
pages = {e0347426},
doi = {10.1371/journal.pone.0347426}
}
EUVIMED